FDA approves Dotarem imaging agent in patients ages <2

FDA approved Dotarem gadoterate meglumine from Guerbet S.A. (Euronext:GBT) for use in MRI imaging to detect and visualize areas with disruption of the blood-brain barrier and/or abnormal vascularity ...